Truscreen Group Ltd
TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The comp… Read more
Truscreen Group Ltd (TRU) - Net Assets
Latest net assets as of September 2025: AU$3.35 Million AUD
Based on the latest financial reports, Truscreen Group Ltd (TRU) has net assets worth AU$3.35 Million AUD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$4.30 Million) and total liabilities (AU$951.80K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$3.35 Million |
| % of Total Assets | 77.87% |
| Annual Growth Rate | -19.11% |
| 5-Year Change | -91.08% |
| 10-Year Change | -92.87% |
| Growth Volatility | 39.15 |
Truscreen Group Ltd - Net Assets Trend (2013–2024)
This chart illustrates how Truscreen Group Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Truscreen Group Ltd (2013–2024)
The table below shows the annual net assets of Truscreen Group Ltd from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | AU$1.01 Million | -68.80% |
| 2023-12-31 | AU$3.23 Million | +27.14% |
| 2022-12-31 | AU$2.54 Million | -25.13% |
| 2021-12-31 | AU$3.40 Million | -69.98% |
| 2020-12-31 | AU$11.31 Million | +56.18% |
| 2019-12-31 | AU$7.24 Million | -36.04% |
| 2018-12-31 | AU$11.32 Million | -2.54% |
| 2017-12-31 | AU$11.62 Million | -18.91% |
| 2016-12-31 | AU$14.32 Million | +1.26% |
| 2015-12-31 | AU$14.15 Million | +43.51% |
| 2014-12-31 | AU$9.86 Million | -5.24% |
| 2013-12-31 | AU$10.40 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Truscreen Group Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3588982300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$38.77 Million | 3844.99% |
| Other Comprehensive Income | AU$-293.75K | -29.13% |
| Total Equity | AU$1.01 Million | 100.00% |
Truscreen Group Ltd Competitors by Market Cap
The table below lists competitors of Truscreen Group Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MODELON AB AK B
F:3VM1
|
$4.80 Million |
|
UPA Corporation Bhd
KLSE:7757
|
$4.80 Million |
|
Peak Minerals Limited
PINK:HEGLF
|
$4.80 Million |
|
Kalgoorlie Gold Mining Limited
PINK:KALMF
|
$4.81 Million |
|
Mr. Onion
TWO:2740
|
$4.80 Million |
|
Archidply Industries Limited
NSE:ARCHIDPLY
|
$4.80 Million |
|
Greenway Greenhouse Cannabis Corporation
OTCQB:GWAYF
|
$4.80 Million |
|
Citigold Corporation Limited
PINK:CTOHF
|
$4.80 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Truscreen Group Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,231,934 to 1,008,382, a change of -2,223,552 (-68.8%).
- Net loss of 2,243,476 reduced equity.
- Other comprehensive income decreased equity by 191,082.
- Other factors increased equity by 211,006.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-2.24 Million | -222.48% |
| Other Comprehensive Income | AU$-191.08K | -18.95% |
| Other Changes | AU$211.01K | +20.93% |
| Total Change | AU$- | -68.80% |
Book Value vs Market Value Analysis
This analysis compares Truscreen Group Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.13x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.10x to 7.13x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | AU$0.13 | AU$0.01 | x |
| 2014-12-31 | AU$0.07 | AU$0.01 | x |
| 2015-12-31 | AU$0.09 | AU$0.01 | x |
| 2016-12-31 | AU$0.09 | AU$0.01 | x |
| 2017-12-31 | AU$0.06 | AU$0.01 | x |
| 2018-12-31 | AU$0.05 | AU$0.01 | x |
| 2019-12-31 | AU$0.03 | AU$0.01 | x |
| 2020-12-31 | AU$0.03 | AU$0.01 | x |
| 2021-12-31 | AU$0.01 | AU$0.01 | x |
| 2022-12-31 | AU$0.01 | AU$0.01 | x |
| 2023-12-31 | AU$0.01 | AU$0.01 | x |
| 2024-12-31 | AU$0.00 | AU$0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Truscreen Group Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -222.48%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -131.04%
- • Asset Turnover: 0.93x
- • Equity Multiplier: 1.83x
- Recent ROE (-222.48%) is below the historical average (-70.72%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -22.79% | -8173.33% | 0.00x | 1.11x | AU$-3.41 Million |
| 2014 | -7.02% | -43.95% | 0.15x | 1.08x | AU$-1.68 Million |
| 2015 | -9.17% | -274.71% | 0.03x | 1.03x | AU$-2.71 Million |
| 2016 | -24.72% | -604.83% | 0.04x | 1.05x | AU$-4.97 Million |
| 2017 | -38.51% | -556.34% | 0.07x | 1.05x | AU$-5.63 Million |
| 2018 | -30.94% | -163.44% | 0.17x | 1.11x | AU$-4.63 Million |
| 2019 | -71.77% | -403.40% | 0.16x | 1.12x | AU$-5.92 Million |
| 2020 | -30.86% | -176.79% | 0.16x | 1.06x | AU$-4.62 Million |
| 2021 | -232.48% | -309.68% | 0.58x | 1.29x | AU$-8.23 Million |
| 2022 | -94.49% | -144.46% | 0.48x | 1.37x | AU$-2.66 Million |
| 2023 | -63.45% | -78.80% | 0.65x | 1.25x | AU$-2.37 Million |
| 2024 | -222.48% | -131.04% | 0.93x | 1.83x | AU$-2.34 Million |
Industry Comparison
This section compares Truscreen Group Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $14,750,885
- Average return on equity (ROE) among peers: -315.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Truscreen Group Ltd (TRU) | AU$3.35 Million | -22.79% | 0.28x | $4.80 Million |
| 4DMEDICAL Ltd (4DX) | $926.64K | -85.93% | 0.18x | $1.03 Billion |
| Adherium Ltd (ADR) | $34.53 Million | -3.63% | 0.08x | $2.37 Million |
| Aroa Biosurgery Ltd (ARX) | $-22.65 Million | 0.00% | 0.00x | $92.74 Million |
| Atomo Diagnostics Ltd (AT1) | $34.48 Million | -26.73% | 0.05x | $8.96 Million |
| Control Bionics Ltd (CBL) | $6.09 Million | -15.97% | 0.04x | $4.98 Million |
| Cardiex Ltd (CDX) | $3.03 Million | -101.61% | 0.73x | $4.25 Million |
| Compumedics Ltd (CMP) | $9.21 Million | -30.70% | 1.16x | $13.08 Million |
| Cochlear Ltd (COH) | $75.42 Million | 53.19% | 1.13x | $7.01 Billion |
| Cleo Diagnostics Ltd (COV) | $5.83 Million | -68.54% | 0.19x | $23.47 Million |
| Conneqt Health Limited (CQT) | $633.50K | -2871.98% | 13.72x | $4.66 Million |